Kala Danushkodi, MD
Physical Medicine & Rehabilitation · North Kansas City, MONPI 1780640276
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $406 and has fallen 64.6% since, to $144 in 2025.
Across 70 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zyla Life Sciences, Inc.$237
- Merz Pharmaceuticals, LLC$179
- Pfizer$141
- Merz North America, Inc.$108
- Scilex Pharmaceuticals Inc.$56
- Microtransponder, Inc.$56
- plus $397 from 15 others
What the payments were for
- Food & beverage$1,170100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zyla Life Sciences, Inc. | 22 | $237 |
| Merz Pharmaceuticals, LLC | 7 | $179 |
| Pfizer | 9 | $141 |
| Merz North America, Inc. | 5 | $108 |
| Scilex Pharmaceuticals Inc. | 3 | $56 |
| Microtransponder, Inc. | 1 | $56 |
| Alnylam Pharmaceuticals Inc. | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $46 |
| Sentynl Therapeutics, Inc. | 3 | $44 |
| AbbVie | 2 | $41 |
| ANI Pharmaceuticals, Inc. | 2 | $39 |
| Medtronic | 1 | $32 |
| Dynasplint Systems Inc. | 1 | $28 |
| Vertex | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $15 |
| Assertio Therapeutics, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
How this compares
$1,174 in reported general payments places this provider in the 80th percentile of 182 physical medicine & rehabilitation providers in Missouri.
See all physical medicine & rehabilitation providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 144 | $2,144 |
| Fentanyl | 21 | $1,553 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 101 | $1,387 |
| Morphine Sulfate ErMorphine Sulfate | 45 | $1,327 |
| Gabapentin | 59 | $665 |
| Pregabalin | 14 | $617 |
| Morphine Sulfate | 22 | $517 |
| Baclofen | 19 | $478 |
| Tramadol Hcl | 43 | $289 |
| Ibuprofen | 14 | $143 |
| Cyclobenzaprine Hcl | 24 | $81 |
| Meloxicam | 17 | $33 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in North Kansas City
- Lizette AlvarezSaint Louis$182K
- Heidi HunterCape Girardeau$150K
- Constantine FotopoulosKansas City$91K
- Joseph BurrisColumbia$75K
- Alexander ChamessianCreve Coeur$55K
- Jane EmersonColumbia$44K
- Reza FaridColumbia$37K
- Nathan KenyonJefferson City$24K
- Kunj PatelSaint Louis$17K
- Vovanti JonesColumbia$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.